The history of CHIPSA Hospital is in a way, the history of Gerson Therapy itself. We are known as the Gerson Therapy hospital because our hospital was founded by Charlotte Gerson, the daughter of Max Gerson, the man who created the Gerson Immuno-Nutrition Protocol. The hospital that is now CHIPSA began using the Gerson Protocols […]
Continue readingLast September, hundreds of people made history as they attended an event uniting 22 terminal cancer survivors with top scientists and doctors in the field of cancer. The group of patients gathered there certainly seemed to have more differences than similarities. They lived in different places around the country. They held different occupations. They came […]
Continue readingLast November, CHIPSA Hospital hosted a unique, first-of-its-kind event celebrating the lives of 22 late stage cancer survivors who, according to doctors, shouldn’t even be alive. Surrounded by world-renowned doctors, scientists, and researchers, these patients shared their inspiring stories of how they healed their terminal disease when conventional treatment had failed them. […]
Continue readingJohn D. was diagnosed with stage 4 squamous cell and basal cell carcinoma in his neck over three years ago. Last year, John had developed a fluid-filled sac on his neck that began to change, harden, and grow. The growth eventually spread throughout […]
Continue readingRussell W. was given 6 months to live back in 2018 after his non-Hodgkin’s lymphoma spread to his skin. But now, nearly 14 months later, he is alive, well, and eager to share his story. Russell’s journey began when he noticed a swollen lymph node near his elbow back in 2016. […]
Continue readingThe KEYNOTE-054 Phase 3 clinical trial (NCT02362594) showed that the immune checkpoint inhibitor drug Keytruda decreased the risk of melanoma recurrence or death by 43% in comparison to a placebo drug. The drug has thus been approved by the U.S. Food and Drug Administration (FDA) to treat patients with stage-3 melanoma (cancer has spread to […]
Continue readingA recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]
Continue readingA recent study published in Nature Genetics called “Tumor mutational load predicts survival after immunotherapy across multiple cancer types” revealed that tumors with more mutations had better results with immunotherapy treatment. The study looked at data from 1,662 metastatic cancer patients who received checkpoint inhibitor therapy, and data from over 5,000 patients who were not treated […]
Continue readingPeople from all around the world are reading about Chipsa and then heading to CHIPSA Hospital in Mexico to treat their cancer. Our full-service community hospital overlooking the Pacific Ocean in Playas de Tijuana offers several integrative treatments and immunological therapies. We treat patients at all stages, including those with advanced, late-stage disease. It […]
Continue readingA research team from the University of Maryland is utilizing artificial intelligence (AI) to determine the most effective ways to treat cancer patients with immunotherapy. Immunotherapy takes advantage of the body’s own immune system to fight off cancer, and in the past decade, it has been very successful in treating patients with localized and advanced […]
Continue reading